Page 108 - Read Online
P. 108

Page 30 of 32                 Noor et al. Neuroimmunol Neuroinflammation 2019;6:10  I  http://dx.doi.org/10.20517/2347-8659.2019.18

               39.  Wang Y, Kai H, Chang F, Shibata K, Tahara-Hanaoka S, et al. A critical role of LFA-1 in the development of Th17 cells and induction
                   of experimental autoimmune encephalomyelytis. Biochem Biophys Res Commun 2007;353:857-62.
               40.  Wang JG, Collinge M, Ramgolam V, Ayalon O, Fan XC, et al. LFA-1-dependent HuR nuclear export and cytokine mRNA stabilization
                   in T cell activation. J Immunol 2006;176:2105-13.
               41.  Zhang Y, Wang H. Integrin signalling and function in immune cells. Immunology 2012;135:268-75.
               42.  Lam NCK, Ornatowski W, Alberti LB, Wilkerson JL, Moezzi D, et al. The role of leukocyte accumulation and diminshed spinal IL-10
                   expression in chronic neuropathy. Poster session presented at : Society for Neuroscience meeting; Washington DC; 2014.
               43.  Suzuki J, Yamasaki S, Wu J, Koretzky GA, Saito T. The actin cloud induced by LFA-1-mediated outside-in signals lowers the
                   threshold for T-cell activation. Blood 2007;109:168-75.
               44.  Woska JR, Jr., Shih D, Taqueti VR, Hogg N, Kelly TA, et al. A small-molecule antagonist of LFA-1 blocks a conformational change
                   important for LFA-1 function. J Leukoc Biol 2001;70:329-34.
               45.  Kelly TA, Jeanfavre DD, McNeil DW, Woska JR, Jr, Reilly PL, et al. Cutting edge: a small molecule antagonist of LFA-1-mediated cell
                   adhesion. J Immunol 1999;163:5173-7.
               46.  Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain
                   1988;33:87-107.
               47.  Vanderwall AG, Noor S, Sun MS, Sanchez JE, Yang XO, et al. Effects of spinal non-viral interleukin-10 gene therapy formulated with
                   d-mannose in neuropathic interleukin-10 deficient mice: Behavioral characterization, mRNA and protein analysis in pain relevant
                   tissues. Brain Behav Immun 2018;69:91-112.
               48.  Jensen TS, Finnerup NB. Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms. Lancet Neurol
                   2014;13:924-35.
               49.  Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci
                   Methods 1994;53:55-63.
               50.  Milligan ED, Mehmert KK, Hinde JL, Harvey LO, Martin D, et al. Thermal hyperalgesia and mechanical allodynia produced by
                   intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120. Brain Res 2000;861:105-16.
               51.  Noor S, Sanchez JJ, Vanderwall AG, Sun MS, Maxwell JR, et al. Prenatal alcohol exposure potentiates chronic neuropathic pain,
                   spinal glial and immune cell activation and alters sciatic nerve and DRG cytokine levels. Brain Behav Immun 2017;61:80-95.
               52.  Giblin PA, Lemieux RM. LFA-1 as a key regulator of immune function: approaches toward the development of LFA-1-based
                   therapeutics. Curr Pharm Des 2006;12:2771-95.
               53.  Woska JR, Jr., Last-Barney K, Rothlein R, Kroe RR, Reilly PL, et al. Small molecule LFA-1 antagonists compete with an anti-LFA-1
                   monoclonal antibody for binding to the CD11a I domain: development of a flow-cytometry-based receptor occupancy assay. J Immunol
                   Methods 2003;277:101-15.
               54.  Hosseini BH, Louban I, Djandji D, Wabnitz GH, Deeg J, et al. Immune synapse formation determines interaction forces between T
                   cells and antigen-presenting cells measured by atomic force microscopy. Proc Natl Acad Sci U S A 2009;106:17852-7.
               55.  Mellios N, Woodson J, Garcia RI, Crawford B, Sharma J, et al. beta2-Adrenergic receptor agonist ameliorates phenotypes and corrects
                   microRNA-mediated IGF1 deficits in a mouse model of Rett syndrome. Proc Natl Acad Sci U S A 2014;111:9947-52.
               56.  Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T))
                   Method. Methods 2001;25:402-8.
               57.  Teh PP, Vasanthakumar A, Kallies A. Development and Function of Effector Regulatory T Cells. Prog Mol Biol Transl Sci
                   2015;136:155-74.
               58.  Unutmaz D. RORC2: the master of human Th17 cell programming. Eur J Immunol 2009;39:1452-5.
               59.  Li X, Zheng Y. Regulatory T cell identity: formation and maintenance. Trends Immunol 2015;36:344-53.
               60.  Martinez GJ, Nurieva RI, Yang XO, Dong C. Regulation and function of proinflammatory TH17 cells. Ann N Y Acad Sci
                   2008;1143:188-211.
               61.  Bennett ML, Bennett FC, Liddelow SA, Ajami B, Zamanian JL, et al. New tools for studying microglia in the mouse and human CNS.
                   Proc Natl Acad Sci U S A 2016;113:E1738-46.
               62.  Maxwell JR, Denson JL, Joste NE, Robinson S, Jantzie LL. Combined in utero hypoxia-ischemia and lipopolysaccharide
                   administration in rats induces chorioamnionitis and a fetal inflammatory response syndrome. Placenta 2015;36:1378-84.
               63.  Yellowhair TR, Noor S, Maxwell JR, Anstine CV, Oppong AY, et al. Preclinical chorioamnionitis dysregulates CXCL1/CXCR2
                   signaling throughout the placental-fetal-brain axis. Exp Neurol 2018;301:110-9.
               64.  Fantini MC, Dominitzki S, Rizzo A, Neurath MF, Becker C. In vitro generation of CD4+ CD25+ regulatory cells from murine naive T
                   cells. Nat Protoc 2007;2:1789-94.
               65.  Yosef N, Shalek AK, Gaublomme JT, Jin H, Lee Y, et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature
                   2013;496:461-8.
               66.  Lim MA, Lee J, Park JS, Jhun JY, Moon YM, et al. Increased Th17 differentiation in aged mice is significantly associated with high
                   IL-1beta level and low IL-2 expression. Exp Gerontol 2014;49:55-62.
               67.  Sallin MA, Sakai S, Kauffman KD, Young HA, Zhu J, et al. Th1 Differentiation Drives the Accumulation of Intravascular, Non-
                   protective CD4 T Cells during Tuberculosis. Cell Rep 2017;18:3091-104.
               68.  Andersen P, Smedegaard B. CD4(+) T-cell subsets that mediate immunological memory to Mycobacterium tuberculosis infection in
                   mice. Infect Immun 2000;68:621-9.
               69.  Li LX, McSorley SJ. B cells enhance antigen-specific CD4 T cell priming and prevent bacteria dissemination following Chlamydia
   103   104   105   106   107   108   109   110   111   112   113